Q1 2026 · 13F-HR
Carlyle Group Inc. (CG, CGABL)holdings as filed
Filed 2026-05-08 · accession 0000898432-26-000339
$10.62B
Reported value
20
Positions
2026-03-31
Period end
The Brief · Carlyle Group Inc. (CG, CGABL) · Q1 2026
AI · grounded in 13F
Carlyle Group Inc. closed its position in Nucana Plc NCNA, reducing its holdings by $479,999. The fund also trimmed its stakes in Standardaero Inc SARO by 44.6% and Medline Inc MDLN by 13.1%. Additionally, the fund established a new position in Heartflow Inc HTFL valued at $497,256.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 58507V107 | MDLN | Medline Inc | $8.33B | 78.4% | 187,083,713 | Common | SHARED |
| 85423L103 | SARO | Standardaero Inc | $2.18B | 20.6% | 84,587,035 | Common | SHARED |
| 71722W107 | PHAT | Phathom Pharmaceuticals Inc | $38.8M | 0.37% | 3,496,808 | Common | SHARED |
| 732908108 | PONY | Pony Ai Inc | $22.3M | 0.21% | 2,362,447 | Common | SHARED |
| 46187W107 | INVH | Invitation Homes Inc | $16.5M | 0.16% | 664,100 | Common | SHARED |
| 229663109 | CUBE | CubeSmart | $8.1M | 0.08% | 220,500 | Common | SHARED |
| 746964105 | QTTB | Q32 Bio Inc | $7.1M | 0.07% | 1,102,741 | Common | SHARED |
| 374275105 | GETY | Getty Images Holdings Inc | $4.9M | 0.05% | 6,234,252 | Common | SHARED |
| 85209E208 | SPRB | Spruce Biosciences Inc | $2.5M | 0.02% | 38,620 | Common | SHARED |
| 34986A104 | FWRD | Forward Air Corp | $1.8M | 0.02% | 107,214 | Common | SHARED |
| 007002207 | ACET | Adicet Bio Inc | $1.3M | 0.01% | 184,295 | Common | SHARED |
| 50101L106 | DNUT | Krispy Kreme Inc | $1.2M | 0.01% | 340,748 | Common | SHARED |
| 68277Q105 | OKUR | Onkure Therapeutics Inc | $1.1M | 0.01% | 269,895 | Common | SHARED |
| 471871202 | JSPR | Jasper Therapeutics Inc | $934,195 | 0.01% | 1,066,189 | Common | SHARED |
| 20460L104 | SPWR | SunPower Inc | $550,111 | 0.01% | 433,158 | Common | SHARED |
| 42238D107 | HTFL | Heartflow Inc | $497,256 | 0.00% | 20,438 | Common | SHARED |
| 00773J202 | SYRE | Spyre Therapeutics Inc | $485,233 | 0.00% | 9,620 | Common | SHARED |
| 62878D100 | NABL | N-able Inc | $437,728 | 0.00% | 93,732 | Common | SHARED |
| 30205M309 | XCUR | Exicure Inc | $239,647 | 0.00% | 56,328 | Common | SHARED |
| 770700102 | HOOD | Robinhood Mkts Inc | $233,957 | 0.00% | 3,376 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.